Navidea Biopharmaceuticals Second Quarter 2012 Earnings and Business Update Conference Call Invitation

Published: Jul 31, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that the Company will report its financial results for the second quarter of 2012 on Monday, August 6, 2012 after market close. The announcement of results will be followed by a conference call with the investment community, Tuesday, August 7, 2012 at 8:00 AM EDT.

Back to news